BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.

J Cancer Res Clin Oncol · 2024 · PMC10821830 · PMID 38280040

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

did not reach statistical significancep = 0.087so close (0.05 < p ≤ 0.1)

The median survival was 14.0 months in patients with loss of BAP1 expression and 10.0 months in patients with retained expression in this study, but the difference did not reach statistical significance ( p = 0.087).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.